Featured Announcements

1. $Ascletis Pharma-B(01672.HK)$ : 3CLpro inhibitor ASC11 is expected to become an effective drug for the treatment of new coronary pneumonia

Ascletis Pharma-B announced that its oral small molecule drug candidate ASC11 (3CLpro inhibitor) is expected to become an effective drug for the treatment of new coronary pneumonia. It is reported that ASC11 is an oral small molecule drug candidate independently developed using proprietary technologies including molecular simulation docking, targeting 3CLpro, and has global intellectual property rights.

2. $Yitai Coal (03948.HK)$ realized a gross profit of 5.475 billion yuan in the first quarter, a year-on-year increase of 117.09%

Yitai Coal announced that in the first quarter of this year, sales revenue was 12.143 billion yuan, an increase of 48.8% year-on-year; sales cost was 6.668 billion yuan, an increase of 18.2%; gross profit was 5.475 billion yuan, an increase of 117.1%. During the quarter, coal output was 12,396,700 tons, an increase of 28.9% year-on-year; coal sales were 17,317,400 tons, a slight increase of 0.5%.

3. $CHALCO (02068.HK)$ The value of newly signed contracts in the first quarter was 11.011 billion yuan, a year-on-year increase of 50.32%

Chinalco International announced that in the first quarter of 2022, the company signed 1,583 new contracts with a value of RMB 11.011 billion, a year-on-year increase of 50.32%.

4. $Li Ning (02331.HK)$ : same-store sales in the first quarter achieved a low growth of 20%-30% year-on-year

From the perspective of same-store sales, Li Ning (excluding Li-Ning YOUNG) recorded a low growth of 20% to 30% year-on-year in the same-store sales of the entire platform. In terms of channels, the retail (direct sales) channel recorded a mid-segment growth of 20% to 30%, and the wholesale (franchise) channel recorded a low-segment growth of 10% to 20%. The e-commerce store business is growing in the mid-30% to 40% range year-on-year.

5. $China Tower (00788.HK)$ The profit attributable to shareholders in the first quarter was 2.18 billion yuan, a year-on-year increase of 28.7%

China Tower announced that in the first quarter of this year, it achieved operating income of 22.633 billion yuan, an increase of 7% year-on-year. EBITDA recorded 15.682 billion yuan, a slight increase of 0.8%, and the EBITDA ratio was 69.3%. Profit attributable to shareholders was 2.18 billion yuan, an increase of 28.7%.

• Major issues

GCL-Poly Energy (03800) and TCL Technology plan to jointly invest 12 billion yuan to build photovoltaic-grade and electronic-grade silicon material projects

China Jinmao (00817) and Sinochem Factoring entered into a new framework agreement

Minmetals Resources (01208): Las Bambas will not be able to sustain copper production

China Huarong (02799) released information on the equity transfer of Huarong Xiangjiang Bank at the Beijing Gold Exchange and the listing price was 11.9807 billion yuan

Hong Kong Aerospace Science and Technology (01725) subsidiary Jinan Port Aviation and SDIISIT intend to cooperate in the construction and operation of agricultural satellite constellations

Connoya-B(02162) New Drug Candidate CMG901 Granted Fast Track Designation by U.S. FDA

Sino Biopharmaceutical (01177): The anti-tumor drug “Anlotinib Hydrochloride Capsules” was approved for the fifth indication

BeiGene (06160): The State Food and Drug Administration approved Baizean® for second-line treatment of esophageal squamous cell carcinoma

Ascletis Pharma-B(01672): 3CLpro inhibitor ASC11 is expected to be an effective drug for the treatment of new coronary pneumonia

BeiGene (06160): Updated data analysis of Phase 3 clinical trial RATIONALE-309 to be presented at ASCO meeting

Henlius (02696): Phase 1 clinical study of HLX20 in the treatment of advanced solid tumors shows that it is safe and well tolerated

Clover Bio-B(02197): Presenting latest persistence and booster data for COVID-19 vaccine candidates at the 2022 World Vaccine Congress in Washington

• Financial report data

361 Degrees (01361): The retail sales of the main brand products in the first quarter achieved high double-digit growth compared with the same period of the previous year

Yitai Coal (03948) achieved a gross profit of 5.475 billion yuan in the first quarter, a year-on-year increase of 117.09%

Pure City Technology (09911) expects social business revenue in the first quarter of 625 to 650 million yuan, a year-on-year increase of about 65%

China Aluminum International (02068) The value of newly signed contracts in the first quarter was 11.011 billion yuan, a year-on-year increase of 50.32%

Li Ning (02331): same-store sales in the first quarter achieved a low growth of 20%-30% year-on-year

Profit attributable to shareholders of China Tower (00788) in the first quarter was 2.18 billion yuan, a year-on-year increase of 28.7%

Huadian International Power Co., Ltd. (01071) completed a total of 56.08 million MWh of power generation in the first quarter, a year-on-year decrease of 10.62%

Shandong Xinhua Pharmaceutical Co., Ltd. (00719) released its first-quarter results. Net profit attributable to the parent company was approximately RMB 109 million, an increase of 8.20% year-on-year.

Sunshine Energy (00757) revenue in the first quarter was 1.107 billion yuan, a year-on-year increase of 5.7%

Sinopec Refining and Chemical Engineering (02386) The total value of newly signed contracts in the first quarter was 31.37 billion yuan, an increase of 4.9% year-on-year

China Railway Construction (01186) The value of newly signed contracts in the first quarter was 465.9382 billion yuan, a year-on-year increase of 1.53%

Shandong Gold (01787) released its first quarter results, and its net profit attributable to the parent was about 315 million yuan, turning losses into profits year-on-year

China Taiping (00966): Taiping Life Insurance’s original insurance premium in the first quarter was 56.174 billion yuan

Fast Retailing (06288) interim profit attributable to shareholders of 146.844 billion yen to resume trading on April 19

Joy City Real Estate (00207) contracted sales of approximately RMB 6.96 billion in the first quarter

Legend Holdings (03396) announced the first quarter results of its subsidiary Lianhong Xinke, with an operating income of 1.556 billion yuan

Legend Holdings (03396) released the first quarter results of its subsidiary Joyvio Foods, with a net profit attributable to the parent of RMB 110 million, turning losses into profits year-on-year

China Resources Pharmaceutical (03320) subsidiary Dong’e Ejiao issued a positive profit, expecting a net profit of 100 million to 120 million yuan attributable to the parent in the first quarter

• Increase or decrease holdings

China Merchants Port (00144) accumulatively increased its holdings of SIPG to 28.06%

• repurchase cancellation

AIA (01299) on April 19 spent about HK$163 million to repurchase 2,080,800 shares

Standard Chartered Group (02888) repurchased 1.67 million shares at £8.46 million on April 14

Kingsoft (03888) repurchased 433,000 shares at a cost of approximately HK$9,967,400 on April 19

Mingyuan Cloud (00909) repurchased 970,000 shares at a cost of about HK$9,300,300 on April 19

• Additional placement

KWG Group (01813) issued 1,093,200 shares for share award plan

Jiahe Bio-B (06998) issued 16,250 shares due to the vesting of restricted share units

Xpeng Motors-W (09868) issued approximately 73,750 shares under the 2019 Equity Incentive Plan

• Equity incentive

Smol International (06969) granted a total of 6.354 million award shares

Tradelink (00536) granted 7.4 million share options

Kingsoft (03888) repurchased 433,000 shares at a cost of HK$9.967 million on April 19

Saisheng Pharmaceutical (06600) granted 18.046 million share options and a total of 2.41 million RSUs

Straw Bear Entertainment (02125) granted a total of 3.859 million RSUs

• dividends

Poly Property (06049) plans to distribute a final dividend of 0.305 yuan per share on August 5

China Tongfu (01763) will distribute a final dividend of 37.79 cents per share on July 23

This article is reprinted from: https://news.futunn.com/post/14673036?src=3&report_type=market&report_id=203468&futusource=news_headline_list
This site is for inclusion only, and the copyright belongs to the original author.